测试版
试验雷达 AI
临床试验 NCT07193329 针对心理困扰，恶性肿瘤目前招募中。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。
一个试验符合筛选条件
卡片视图
返回搜索

Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life 2,000 观察性

招募中
临床试验详情主要以英语提供。然而，试验雷达 AI可以提供帮助！只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT07193329是一项针对心理困扰，恶性肿瘤的观察研究试验，目前试验状态为招募中。试验始于2025年7月22日，计划招募2,000名患者。该研究由Gang Chen, MD主导，预计于2028年7月1日完成。试验数据来源于ClinicalTrials.gov，最后更新时间为2025年9月25日。
简要概括
The goal of this observational study is to learn about the Psychological Distress in Malignant Tumor Patients about Effects on Treatment Adherence, Outcomes, and Quality of Life. The main question it aims to answer is:

Does Psychological Distress affect Malignant Tumor Patients' Effects on Treatment Adherence, Outcomes, and Quality of Life? Malignant Tumor Patients with or without Psychological Distress will answer ...

显示更多
官方标题

Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life

疾病
心理困扰恶性肿瘤
其他研究标识符
  • KY2025-235
NCT编号
NCT07193329
实际开始日期
2025-07-22
最近更新发布
2025-09-25
预计完成日期
2028-07-01
计划入组人数
2,000
研究类型
观察研究
试验状态
招募中
试验组/干预措施
参与者组/试验组干预措施/治疗方法
Malignant Tumor Patients with Psychological Distress
不适用
Malignant Tumor Patients without Psychological Distress
不适用
主要终点
结果指标度量标准描述时间框架
Objective Response Rate (ORR) by mRECIST (%)
Proportion of participants achieving complete response (CR) or partial response (PR) based on mRECIST criteria, measured on contrast-enhanced CT/MRI.
at 4-12 weeks after treatment initiation.
参与助手
资格标准

适龄参与研究
成人, 老年人
最低年龄要求
18 Years
适龄性别
全部
  • (1) Confirmed malignant tumors by imaging or pathology (such as hepatobiliary carcinoma, gastric cancer, breast cancer, lung cancer, etc.)
  • (2) Planning to receive or currently undergoing systemic treatment (such as surgery, chemotherapy, TACE, targeted therapy, etc.)
  • (3) Age ≥18 years old
  • (4) Sign the informed consent form and voluntarily participate in this study

  • (1) Combined with severe systemic diseases (such as severe cardiovascular and cerebrovascular diseases)
  • (2) There is severe cognitive impairment and it is impossible to complete the questionnaire assessment
  • (3) Incomplete clinical data or loss to follow-up
Gang Chen, MD logoGang Chen, MD
研究责任方
Gang Chen, MD, 申办者-研究者, M.D., Ph.D., Professor, First Affiliated Hospital of Wenzhou Medical University
没有联系数据。
1 位于 1 个国家/地区的研究中心

Zhejiang

First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China
Gang Chen, MD, 联系人, 86+13616619566, [email protected]
招募中